Loperamide in the treatment of acute gastroenteritis in early childhood. Report of a two centre, double-blind, controlled clinical trial
Abstract
Loperamide at a dose of 0 . 2 mg/kg/day was compared with placebo in the treatment of acute infantile gastro-enteritis in hospital-based double-blind clinical trials carried out in parallel in Liverpool, England and Benghazi, Libya. Fifty patients aged one month to four years entered the study in ea …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
Child
Infant
preschool
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Body Weight
length of stay
escherichia coli / isolation & purification
rotavirus / isolation & purification
drug evaluation
pmid:6185060
doi:10.1080/02724936.1981.11748077
j r owens
r broadhead
r n gangal
gastroenteritis / drug therapy*
gastroenteritis / microbiology
loperamide / therapeutic use*
piperidines / therapeutic use*
prostaglandins e / antagonists & inhibitors
Access
Citation
ID:
114724
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114724
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
